Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placeboUmesh A. Badrising, Axel R. Wintzen, Aeilko H. Zwinderman et al.|Annals of Neurology|2002Cited by 132
Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic dataRianne MF van Schie, Judith A.M. Wessels, Saskia le Cessie et al.|European Heart Journal|2011Cited by 97